Exelixis
EXEL
#1680
Rank
C$14.21 B
Marketcap
$49.78
Share price
2.24%
Change (1 day)
67.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company